Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to ad5 and protect nonhuman primates against ebolavirus challenge

  • Thomas W. Geisbert
  • , Michael Bailey
  • , Lisa Hensley
  • , Clement Asiedu
  • , Joan Geisbert
  • , Daphne Stanley
  • , Anna Honko
  • , Joshua Johnson
  • , Sabue Mulangu
  • , Maria Grazia Pau
  • , Jerome Custers
  • , Jort Vellinga
  • , Jenny Hendriks
  • , Peter Jahrling
  • , Mario Roederer
  • , Jaap Goudsmit
  • , Richard Koup
  • , Nancy J. Sullivan

Research output: Contribution to journal › Article › peer-review

199 Scopus citations

Fingerprint

Dive into the research topics of 'Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to ad5 and protect nonhuman primates against ebolavirus challenge'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology